Idioma:

Precision Population Medicine in Primary Care: The Sanford Chip Experience

Christensen, Kurt D ; Bell, Megan ; Zawatsky, Carrie L B ; Galbraith, Lauren N ; Green, Robert C ; Hutchinson, Allison M ; Jamal, Leila ; LeBlanc, Jessica L ; Leonhard, Jennifer R ; Moore, Michelle ; Mullineaux, Lisa ; Petry, Natasha ; Platt, Dylan M ; Shaaban, Sherin ; Schultz, April ; Tucker, Bethany D ; Van Heukelom, Joel ; Wheeler, Elizabeth ; Zoltick, Emilie S ; Hajek, Catherine

Frontiers in genetics, 2021-03, Vol.12, p.626845-626845 [Periódico revisado por pares]

Switzerland: Frontiers Media S.A

Texto completo disponível

Citações Citado por

Enviar para

Título:
Precision Population Medicine in Primary Care: The Sanford Chip Experience
Autor: Christensen, Kurt D ; Bell, Megan ; Zawatsky, Carrie L B ; Galbraith, Lauren N ; Green, Robert C ; Hutchinson, Allison M ; Jamal, Leila ; LeBlanc, Jessica L ; Leonhard, Jennifer R ; Moore, Michelle ; Mullineaux, Lisa ; Petry, Natasha ; Platt, Dylan M ; Shaaban, Sherin ; Schultz, April ; Tucker, Bethany D ; Van Heukelom, Joel ; Wheeler, Elizabeth ; Zoltick, Emilie S ; Hajek, Catherine
Assuntos: decision support systems – clinical ; genetic counseling ; genetic testing ; Genetics ; pharmacogenomic testing ; primary health care
É parte de: Frontiers in genetics, 2021-03, Vol.12, p.626845-626845
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Chiara Fabbri, King’s College London, United Kingdom; Peter Hulick, NorthShore University Health System, United States
This article was submitted to Genomic Medicine, a section of the journal Frontiers in Genetics
Edited by: Suzette J. Bielinski, Mayo Clinic, United States
Descrição: Genetic testing has the potential to revolutionize primary care, but few health systems have developed the infrastructure to support precision population medicine applications or attempted to evaluate its impact on patient and provider outcomes. In 2018, Sanford Health, the nation's largest rural nonprofit health care system, began offering genetic testing to its primary care patients. To date, more than 11,000 patients have participated in the Sanford Chip Program, over 90% of whom have been identified with at least one informative pharmacogenomic variant, and about 1.5% of whom have been identified with a medically actionable predisposition for disease. This manuscript describes the rationale for offering the Sanford Chip, the programs and infrastructure implemented to support it, and evolving plans for research to evaluate its real-world impact.
Editor: Switzerland: Frontiers Media S.A
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Precision Population Medicine in Primary Care: The Sanford Chip Experience

Switzerland: Frontiers Media S.A

Buscando em bases de dados remotas. Favor aguardar.